Oramed Pharmaceuticals Inc (ORMP)
2.37
+0.04
(+1.72%)
USD |
NASDAQ |
Apr 23, 16:00
2.40
+0.03
(+1.27%)
Pre-Market: 20:00
Oramed Pharmaceuticals Price to Book Value: 0.5862 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.5862 |
| April 22, 2024 | 0.5763 |
| April 19, 2024 | 0.5615 |
| April 18, 2024 | 0.5441 |
| April 17, 2024 | 0.5763 |
| April 16, 2024 | 0.5936 |
| April 15, 2024 | 0.5986 |
| April 12, 2024 | 0.6233 |
| April 11, 2024 | 0.6381 |
| April 10, 2024 | 0.6579 |
| April 09, 2024 | 0.6653 |
| April 08, 2024 | 0.6851 |
| April 05, 2024 | 0.6456 |
| April 04, 2024 | 0.6456 |
| April 03, 2024 | 0.6802 |
| April 02, 2024 | 0.6925 |
| April 01, 2024 | 0.70 |
| March 28, 2024 | 0.7222 |
| March 27, 2024 | 0.6975 |
| March 26, 2024 | 0.6728 |
| March 25, 2024 | 0.6827 |
| March 22, 2024 | 0.7198 |
| March 21, 2024 | 0.6925 |
| March 20, 2024 | 0.7321 |
| March 19, 2024 | 0.70 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.695 |
| March 15, 2024 | 0.7222 |
| March 14, 2024 | 0.6629 |
| March 13, 2024 | 0.6851 |
| March 12, 2024 | 0.7074 |
| March 11, 2024 | 0.7272 |
| March 08, 2024 | 0.7371 |
| March 07, 2024 | 0.7074 |
| March 06, 2024 | 0.7099 |
| March 05, 2024 | 0.8027 |
| March 04, 2024 | 0.8003 |
| March 01, 2024 | 0.8421 |
| February 29, 2024 | 0.8101 |
| February 28, 2024 | 0.8397 |
| February 27, 2024 | 0.8815 |
| February 26, 2024 | 0.8741 |
| February 23, 2024 | 0.852 |
| February 22, 2024 | 0.8126 |
| February 21, 2024 | 0.7904 |
| February 20, 2024 | 0.7757 |
| February 16, 2024 | 0.7732 |
| February 15, 2024 | 0.7732 |
| February 14, 2024 | 0.7707 |
| February 13, 2024 | 0.7461 |
| February 12, 2024 | 0.7806 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4619
Minimum
Nov 01 2023
11.80
Maximum
Feb 17 2021
2.973
Average
2.376
Median
Feb 18 2022
Price to Book Value Benchmarks
| Inogen Inc | 0.7859 |
| Petros Pharmaceuticals Inc | 0.3874 |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.699 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 16.93 |
| PS Ratio | 35.56 |
| Price | 2.37 |
| Earnings Yield | 5.91% |
| Market Cap | 96.03M |